Table 4:
Hazard Ratio | 95% Confidence Interval | P-Value | |
---|---|---|---|
Beta Blocker Exposure | |||
Age 66–74 | |||
1–80 PDC | 0.46 | 0.44, 0.49 | <0.001 |
80+ PDC | 0.37 | 0.35, 0.39 | <0.001 |
Age 75–84 | |||
1–80 PDC | 0.49 | 0.47, 0.51 | <0.001 |
80+ PDC | 0.39 | 0.37, 0.40 | <0.001 |
Age 85+ | |||
1–80 PDC | 0.56 | 0.54, 0.58 | <0.001 |
80+ PDC | 0.43 | 0.42, 0.45 | <0.001 |
ACEi/ARB/ARNI Exposure | |||
Age 66–74 | |||
1–80 PDC | 0.43 | 0.42, 0.45 | <0.001 |
80+ PDC | 0.39 | 0.37, 0.41 | <0.001 |
Age 75–84 | |||
1–80 PDC | 0.45 | 0.44, 0.47 | <0.001 |
80+ PDC | 0.38 | 0.37, 0.40 | <0.001 |
Age 85+ | |||
1–80 PDC | 0.53 | 0.52, 0.55 | <0.001 |
80+ PDC | 0.45 | 0.43, 0.47 | <0.001 |
PDC is proportion of days covered which is the number of days “covered by drug” based on Part D prescription fills over the number of days in the follow-up period
No beta-blocker exposure and no ACEi/ARB exposure is the reference group.
Conditional on survival to 30 days after discharge
Errors are clustered at the hospital referral region level.